Press release
Migraine Drugs Market Report 2024-2033: Size, Share, Growth, Trends, Demand, Key Players, Outlook
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Migraine Drugs Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $6.84 billion In 2028 At A CAGR Of 6.2% :
The migraine drugs market size has grown strongly in recent years. It will grow from $5 billion in 2023 to $5.38 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to advancements in drug formulations, increased awareness and diagnosis, stress and lifestyle factors, expansion of generic drugs, emergence of cgrp inhibitors.
The migraine drugs market size is expected to see strong growth in the next few years. It will grow to $6.84 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to personalized medicine approaches, telemedicine and remote consultations, healthcare policy and insurance coverage, increasing global migraine burden, combination therapies. Major trends in the forecast period include targeted therapies, telemedicine and remote consultations, patient-centric approaches, digital therapeutics, biosimilars in migraine treatment, clinical research and trials.
Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp
Migraine Drugs Market Major Segments
The migraine drugs market covered in this report is segmented -
1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants
2) By Route of Administration: Oral, Injectable, Other Routes
3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users
Key Driver - Impact Of Female Demographics On Migraine Drug Market Growth
The growing female population is expected to propel the growth of the migraine drugs market going forward. The female population refers to the total number of females in all age groups who are residents in each country or region during a specific period. The prevalence of migraines is significantly higher in the female population compared to males due to a combination of genetic, hormonal, and environmental factors. For instance, in 2022, according to the World Population Prospects 2022 shared by the United Nations, a US-based intergovernmental organization, the population of females in the world is estimated at 4.00 billion, representing 49.75% of the world population, and it is now expected that females will outnumber males by 2049. Therefore, the growing female population is driving the growth of the migraine drugs market.
Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=13484&type=smp
Prominent Trend - Innovative Developments In Migraine Treatment
Major companies operating in the migraine drugs market are focused on developing innovative products, such as Zavzpret, to better serve patients and gain a competitive edge in the market. Zavzpret is a nasal spray medication developed for the acute treatment of migraines with or without aura in adults. For instance, in March 2023, Pfizer, a US-based pharmaceutical company, received approval from the Food and Drug Administration, a US-based federal agency, for Zavzpret. It is the first and only approved zavegepant (CGRP receptor antagonist) nasal spray for the acute treatment of migraine. It targets the calcitonin gene-related peptide (CGRP) and is designed for the acute treatment of migraine. The approval of Zavzpret provides a new treatment option for individuals with migraines, especially for those who have nausea and vomiting with migraine attacks and for those who can't use triptans because of cardiovascular risks.
Migraine Drugs Market Players
Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddys Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.
View The Full Report Here - https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report
Largest And Fastest Growing Region In The Market
North America was the largest region in the migraine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Migraine Drugs Market Report Structure
3. Migraine Drugs Market Trends And Strategies
4. Migraine Drugs Market - Macro Economic Scenario
5. Migraine Drugs Market Size And Growth
…..
27. Migraine Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
Migraine Drugs Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $6.84 billion In 2028 At A CAGR Of 6.2% :
The migraine drugs market size has grown strongly in recent years. It will grow from $5 billion in 2023 to $5.38 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to advancements in drug formulations, increased awareness and diagnosis, stress and lifestyle factors, expansion of generic drugs, emergence of cgrp inhibitors.
The migraine drugs market size is expected to see strong growth in the next few years. It will grow to $6.84 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to personalized medicine approaches, telemedicine and remote consultations, healthcare policy and insurance coverage, increasing global migraine burden, combination therapies. Major trends in the forecast period include targeted therapies, telemedicine and remote consultations, patient-centric approaches, digital therapeutics, biosimilars in migraine treatment, clinical research and trials.
Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp
Migraine Drugs Market Major Segments
The migraine drugs market covered in this report is segmented -
1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants
2) By Route of Administration: Oral, Injectable, Other Routes
3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users
Key Driver - Impact Of Female Demographics On Migraine Drug Market Growth
The growing female population is expected to propel the growth of the migraine drugs market going forward. The female population refers to the total number of females in all age groups who are residents in each country or region during a specific period. The prevalence of migraines is significantly higher in the female population compared to males due to a combination of genetic, hormonal, and environmental factors. For instance, in 2022, according to the World Population Prospects 2022 shared by the United Nations, a US-based intergovernmental organization, the population of females in the world is estimated at 4.00 billion, representing 49.75% of the world population, and it is now expected that females will outnumber males by 2049. Therefore, the growing female population is driving the growth of the migraine drugs market.
Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=13484&type=smp
Prominent Trend - Innovative Developments In Migraine Treatment
Major companies operating in the migraine drugs market are focused on developing innovative products, such as Zavzpret, to better serve patients and gain a competitive edge in the market. Zavzpret is a nasal spray medication developed for the acute treatment of migraines with or without aura in adults. For instance, in March 2023, Pfizer, a US-based pharmaceutical company, received approval from the Food and Drug Administration, a US-based federal agency, for Zavzpret. It is the first and only approved zavegepant (CGRP receptor antagonist) nasal spray for the acute treatment of migraine. It targets the calcitonin gene-related peptide (CGRP) and is designed for the acute treatment of migraine. The approval of Zavzpret provides a new treatment option for individuals with migraines, especially for those who have nausea and vomiting with migraine attacks and for those who can't use triptans because of cardiovascular risks.
Migraine Drugs Market Players
Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddys Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.
View The Full Report Here - https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report
Largest And Fastest Growing Region In The Market
North America was the largest region in the migraine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Migraine Drugs Market Report Structure
3. Migraine Drugs Market Trends And Strategies
4. Migraine Drugs Market - Macro Economic Scenario
5. Migraine Drugs Market Size And Growth
…..
27. Migraine Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
